Glycated Serum Albumin

Serum albumin that has undergone, in vivo, spontaneous, non-enzymatic modification with reducing sugars via the MAILLARD REACTION. They are analyzed to measure control of HYPERGLYCEMIA.

Also Known As:

Albumin, Glycated Serum; Albumin, Glycosylated Serum; Albumin, Serum Glycated; Glycosyl Albumin; Serum Albumin, Glycated; Serum Glycated Albumin; Glycated Albumin, Serum; Glycoalbumin; Glycosyl-Albumin; Glycosylated Serum Albumin; Serum Albumin, Glycosylated

Carbohydrates: 22516
- Glycoconjugates: 1370
  - Glycoproteins: 25180
    - Glycated Proteins: 123
      - Glycated Serum Proteins: 93
        Glycated Serum Albumin: 88
  - Advanced Glycation End Products: 4714
    - Glycated Proteins: 123
      - Glycated Serum Proteins: 93
        Glycated Serum Albumin: 88
Amino Acids, Peptides, and Proteins: 1
- Proteins: 496323
  - Albumins: 32609
    - Serum Albumin: 10146
      - Glycated Serum Albumin: 88
  - Glycoproteins: 25180
    - Glycated Proteins: 123
      - Glycated Serum Proteins: 93
        Glycated Serum Albumin: 88
  - Blood Proteins: 12679
    - Serum Albumin: 10146
      - Glycated Serum Albumin: 88
    - Glycated Serum Proteins: 93
      - Glycated Serum Albumin: 88
Biological Factors: 2560
- Biological Toxins: 20
  - Advanced Glycation End Products: 4714
    - Glycated Proteins: 123
      - Glycated Serum Proteins: 93
        Glycated Serum Albumin: 88

Japan Diabetes Society's Committee on Research on Type 1 Diabetes Selected Research

Japan Diabetes Society's Committee on Research on Type 1 Diabetes Research Topics

Disease

Drug/Important Bio-Agent (IBA)